Evidence map›Paper›PMID 34641303›Full record

ArticleMolecules (Basel, Switzerland)2021

Antimicrobial Activity of Gemini Surfactants with Ether Group in the Spacer Part.

Bogumil Eugene Brycki, Adrianna Szulc, Iwona Kowalczyk, Anna Koziróg, Ewelina Sobolewska

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Fabrication of Encapsulated Gemini Surfactants.Molecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bogumil Eugene BryckiDepartment of Bioactive Products, Faculty of Chemistry, Adam Mickiewicz University Poznan, 61-614 Poznan, Poland.
Adrianna SzulcDepartment of Bioactive Products, Faculty of Chemistry, Adam Mickiewicz University Poznan, 61-614 Poznan, Poland.
Iwona KowalczykDepartment of Bioactive Products, Faculty of Chemistry, Adam Mickiewicz University Poznan, 61-614 Poznan, Poland.
Anna KozirógInstitute of Fermentation Technology and Microbiology, Faculty of Biotechnology and Food Science, Lodz University of Technology, 90-924 Lodz, Poland.ORCID 0000-0002-8967-5076
Ewelina SobolewskaInterdisciplinary Doctoral School of the Lodz University of Technology, Lodz University of Technology, 90-924 Lodz, Poland.ORCID 0000-0003-0554-0578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to their large possibility of the structure modification, alkylammonium gemini surfactants are a rapidly growing class of compounds. They exhibit significant surface, aggregation and antimicrobial properties. Due to the fact that, in order to achieve the desired utility effect, the minimal concentration of compounds are used, they are in line with the principle of greenolution (green evolution) in chemistry. In this study, we present innovative synthesis of the homologous series of gemini surfactants modified at the spacer by the ether group, i.e., 3-oxa-1,5-pentane-

Indexed as

Anti-Infective AgentsAspergillus nigerCandida albicansEscherichia coliGreen Chemistry TechnologyMicellesMicrobial Sensitivity TestsMolecular StructurePenicillium chrysogenumQuaternary Ammonium CompoundsStaphylococcus aureusSurface-Active AgentsAnti-Infective AgentsMicellesQuaternary Ammonium CompoundsSurface-Active Agentsantimicrobial activityfunctionalized spacergemini surfactantsMICsurface activity

Identifiers

PMID34641303
PMCPMC8510121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.